Valuation : Xiamen Kingdomway Group Company

Market Cap 10.19B 1.52B 1.31B 1.23B 1.12B 2.1B 143B 2.1B 14.52B 5.63B 73.5B 5.7B 5.57B 237B P/E 2026 *
19.4x
P/E 2027 * 16.9x
Enterprise Value 10.19B 1.52B 1.31B 1.23B 1.12B 2.1B 143B 2.1B 14.52B 5.63B 73.5B 5.7B 5.57B 237B EV / Sales 2026 *
2.61x
EV / Sales 2027 * 2.29x
Free-Float
40.13%
Yield 2026 *
-
Yield 2027 * -
1 day+2.90%
1 week-1.53%
Current month+1.58%
1 month+18.10%
3 months+12.99%
6 months-7.73%
Current year-15.27%
1 week 16.2
Extreme 16.2
17.2
1 month 13.73
Extreme 13.73
17.2
Current year 12.9
Extreme 12.9
20.81
1 year 12.9
Extreme 12.9
22.44
3 years 10.71
Extreme 10.71
22.44
5 years 10.71
Extreme 10.71
34.3
10 years 10.71
Extreme 10.71
64.48
Manager TitleAgeSince
Chief Executive Officer 59 2010-04-17
Director of Finance/CFO 44 2016-04-11
Corporate Officer/Principal 62 2013-04-09
Director TitleAgeSince
Chairman 59 1996-12-31
Director/Board Member 62 2010-04-17
Director/Board Member 60 2022-05-16
Change 5-day change 1-year change 3-year change Capi.($)
+2.90%-1.53%-16.37%-7.22% 1.52B
+0.52%-1.03%+11.64%+64.48% 12.28B
-0.81%-1.17%-23.29%+294.72% 9.1B
+1.23%+0.30%-19.36%-49.25% 2.46B
+0.04%-0.26%+22.12%+79.21% 1.36B
+1.73%-0.40%+25.56%-15.61% 1.3B
-0.10%-2.81%-73.67%-74.57% 1.21B
-1.54%+2.07%-38.54% - 1.15B
-0.35%+4.76%-59.75%-65.68% 1.01B
-0.17%+1.14%-27.44%+14.78% 811M
Average +0.34%+0.29%-19.91%+26.76% 3.22B
Weighted average by Cap. +0.20%-0.25%-9.14%+105.79%

Financials

2026 *2027 *
Net sales 3.91B 582M 501M 471M 430M 805M 54.95B 807M 5.57B 2.16B 28.19B 2.19B 2.14B 90.82B 4.46B 664M 571M 537M 491M 918M 62.65B 921M 6.35B 2.46B 32.14B 2.49B 2.44B 104B
Net income 523M 77.9M 67.03M 63.07M 57.61M 108M 7.36B 108M 745M 289M 3.77B 293M 286M 12.16B 601M 89.52M 77.03M 72.48M 66.21M 124M 8.45B 124M 856M 332M 4.34B 336M 329M 13.97B
Net Debt - -
Logo Xiamen Kingdomway Group Company
Xiamen Kingdomway Group Co is a China-based company principally engaged in the research and development, production and sales of nutritional health foods (including raw materials and end products) and feed additives. The Company's raw materials include coenzyme Q10, Docosahexaenoic Acid (DHA), Arachidonic Acid (ARA), vitamin A, vitamin D3, vitamin K2, nattokinase, pyrroloquinoline quinone (PQQ), Nicotinamide Mononucleotide (NMN), astaxanthin, inositol series products and others. The feed additives produced by the Company include vitamin A, vitamin D3 and others. The Company also produces pharmaceutical raw materials such as praziquantel, alanylglutamine, and oxiracetam. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
2,184
Date Price Change Volume
26-09-04 CN¥16.70 +2.90% 6,333,800
26-09-03 CN¥16.23 -1.34% 3,004,360
26-09-02 CN¥16.45 -2.72% 3,788,283
26-09-01 CN¥16.91 +2.86% 6,701,700
26-08-31 CN¥16.44 -3.07% 4,311,900
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.70CNY
Average target price
22.00CNY
Spread / Average Target
+31.74%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002626 Stock